abstract book

Access here all Abstracts accepted for oral and e-poster presentation at PCR congresses. You can browse by theme, topic or if you know what you are looking for, by author, title using the free search

Tokyo20A-OP002

Impact of aortic valve area for hyper-coagulation status after TAVI

KATAYAMA T. ⁽¹⁾, YOKOYAMA N. ⁽¹⁾, TAKAHASHI S. ⁽¹⁾, NAGURA F. ⁽¹⁾, ITO M. ⁽¹⁾, NOMURA T. ⁽¹⁾, HIOKI H. ⁽¹⁾, KATAOKA A. ⁽¹⁾, WATANABE Y. ⁽¹⁾, KOZUMA K. ⁽¹⁾
(1) Teikyo University, Tokyo JAPAN

Tokyo20A-OP003

Zero contrast TAVI in patients with severe renal dysfunction

YUKIMITSU N. ⁽¹⁾, YUSUKE W. ⁽¹⁾, HIROFUMI H. ⁽¹⁾, AKIHISA K. ⁽¹⁾, KEN K. ⁽¹⁾
(1) Teikyo University, Tokyo JAPAN

Tokyo20A-OP004

Comparison of the results of TAVI in patients with bi- and tricuspid aortic valve with selection of valve size based on annular sizing

CHODóR P. ⁽¹⁾, WILCZEK K. ⁽¹⁾, CHODóR-ROZWADOWSKA K. ⁽²⁾, PRZYBYLSKI R. ⁽¹⁾, GLOWACKI J. ⁽¹⁾, W?OCH ⁽¹⁾, GASIOR M. ⁽¹⁾, ZEMBALA M. ⁽¹⁾, KALARUS Z. ⁽¹⁾
(1) Silesian Center for Heart Diseases, Zabrze POLAND
(2) Students Scientific Society, Medical University of Silesia, Katowice POLAND

Tokyo20A-OP005

Novel dedicated paravalvular leak occluder (VALE project)

WOJAKOWSKI W. ⁽¹⁾, SMOLKA G. ⁽¹⁾, TENDERA M. ⁽¹⁾, DUDEK D. ⁽¹⁾, PLOWIECKI E. ⁽²⁾, PASLAWSKA U. ⁽³⁾, WOJCIECH Z. ⁽⁴⁾
(1) Medical University of Silesia, Katowice POLAND
(2) Balton Sp. z o.o., Warsaw POLAND
(3) Wrocław University of Environmental and Life Sciences, Wrocław POLAND
(4) KCRI, Kraków POLAND

Tokyo20A-OP006

Transition from general anaesthesia to conscious sedation during TAVI, and its positive impact on the cathlab administrational workflow and nursing pre-, peri-, and post-procedural workload in a tertiary hospital in Cyprus

DRAKOMATHIOULAKIS M. ⁽¹⁾, GATIDIS A. ⁽¹⁾, EFTYCHIOU C. ⁽¹⁾, LOUKAIDOU P. ⁽¹⁾, NTAKA A. ⁽¹⁾, AVRAAMIDES P. ⁽¹⁾
(1) Nicosia General Hospital, Strovolos CYPRUS

Tokyo20A-OP008

Impact of beta blockers on patients undergoing TAVR

SAITO T. ⁽¹⁾, HASE H. ⁽¹⁾, YOSHIJIMA N. ⁽¹⁾, HAYASHIDA K. ⁽¹⁾, TSURUTA H. ⁽¹⁾, SHIMIZU H. ⁽¹⁾, TAKAHASHI T. ⁽¹⁾, ITO T. ⁽¹⁾, YAMAZAKI M. ⁽¹⁾, FUKUDA K. ⁽¹⁾
(1) Keio University, Tokyo JAPAN

Tokyo20A-OP009

Incidence and management of severe structural valve degeneration after TAVR: a single-centre experience

LEE Y. T. ⁽¹⁾, YIN W. H. ⁽¹⁾
(1) Cheng Hsin General Hospital, Taipei City TAIWAN

Tokyo20A-OP010

Relationship between intra-operative haemodynamic parameters and delayed haemodynamic recovery after valve deployment in TAVR

KAMEYAMA A. ⁽¹⁾, ITO H. ⁽¹⁾, KAWAKAMI M. ⁽²⁾, UENO H. ⁽¹⁾, FUKAHARA K. ⁽¹⁾
(1) University of Toyama, Toyama JAPAN
(2) Kanazawa University, Ishikawa JAPAN

Tokyo20A-OP011

3D printed silicone casted TAVI training simulator

RUDZINSKI P. N. ⁽¹⁾, KöNIGSHOFER M. ⁽¹⁾, MACH M. ⁽¹⁾, RUSSO M. ⁽¹⁾, WERNER P. ⁽¹⁾, MOSCATO F. ⁽¹⁾, EHRLICH M. ⁽¹⁾, ANDREAS M. ⁽¹⁾
(1) Allgemeines Krankenhaus der Stadt Wien, Vienna AUSTRIA

Tokyo20A-OP012

Inflammatory reaction associated with leaflet thrombosis in the transcatheter aortic valve

SAKU K. ⁽¹⁾, SAKU K. ⁽²⁾, TAKASEYA T. ⁽²⁾, TAHARA N. ⁽²⁾, SASAKI K. ⁽²⁾, OTSUKA H. ⁽²⁾, ITAYA N. ⁽²⁾, HONDA A. ⁽²⁾, SASAKI M. ⁽²⁾, UENO T. ⁽²⁾, TANAKA H. ⁽²⁾
(1) ,
(2) Kurume University, Fukuoka JAPAN

Tokyo20A-OP013

Clinical and haemodynamic outcomes of patients who underwent transcatheter mitral valve-in-valve replacement: one-month results

RAO R. ⁽¹⁾, SUBBAN V. ⁽²⁾, K D. ⁽³⁾, SATISH S. ⁽³⁾, DHARESHWAR J. ⁽⁴⁾, MEHROTRA S. ⁽⁵⁾, ABEDIN H. Z. ⁽⁶⁾, RAJASEKHAR V. ⁽⁷⁾, CHOPRA M. ⁽⁸⁾, MULLASARI S A. ⁽²⁾
(1) Eternal Heart Care Centre, Rajasthan INDIA
(2) The Madras Medical Mission, Tamil Nadu INDIA
(3) Apollo Hospitals, Tamil Nadu INDIA
(4) Jupiter Hospital, Maharashtra INDIA
(5) Narayana Institute of Cardiac Sciences, Karnataka INDIA
(6) Masina Hospital, Maharashtra INDIA
(7) Yashoda Hospitals, Telangana INDIA
(8) Narayana Multispeciality Hospital, Gujarat INDIA

Tokyo20A-OP014

経カテーテル的大動脈弁留置術後の腎機能改善因子の検討

YOKOTA S. ⁽¹⁾, YOKOTA S. ⁽²⁾, YAMANAKA F. ⁽²⁾, SHISHIDO K. ⁽²⁾, NOGUCHI K. ⁽²⁾, SAITO S. ⁽²⁾
(1) ,
(2) Shonan Kamakura General Hospital, Kanagawa JAPAN

Tokyo20A-OP015

Predictive factors of no symptomatic improvement after TAVI

YOSHIJIMA N. ⁽¹⁾, HAYASHIDA K. ⁽¹⁾, KOBARI Y. ⁽¹⁾, MYOJIN S. ⁽¹⁾, RYUZAKI T. ⁽¹⁾, SAITO T. ⁽¹⁾, HASE H. ⁽¹⁾, TSURUTA H. ⁽¹⁾, TAKAHASHI T. ⁽¹⁾, SHIMIZU H. ⁽¹⁾
(1) Keio University Hospital, Tokyo JAPAN

Tokyo20A-OP016

The efficacy of direct visualization of MANTA using ultrasound-navigated technique following large-bore arteriotomy

MORIYAMA N. ⁽¹⁾, LAINE M. ⁽¹⁾
(1) Helsinki University Central Hospital, Helsinki FINLAND

Tokyo20A-OP017

Short- and long-term outcomes of patients with and without end-stage renal disease on dialysis undergoing TAVI: a meta-analysis

KUNO T. ⁽¹⁾, TAKAGI H. ⁽²⁾, ANDO T. ⁽³⁾, UEYAMA H. ⁽¹⁾, KODAIRA M. ⁽⁴⁾, NUMASAWA Y. ⁽⁴⁾, BRIASOULIS A. ⁽⁵⁾, HAYASHIDA K. ⁽⁶⁾
(1) Mount Sinai Beth Israel, NY UNITED STATES
(2) Shizuoka Medical Center, Shizuoka JAPAN
(3) Columbia University, NY UNITED STATES
(4) Japanese Red Cross Ashikaga Hospital, Tochigi JAPAN
(5) University of Iowa Hospitals & Clinics, Iowa UNITED STATES
(6) Keio University Hospital, Tokyo JAPAN

Tokyo20A-OP018

Impact of immunosuppressive therapy on clinical outcomes of severe aortic stenosis treated with TAVI

KAIHARA T. ⁽¹⁾, KAIHARA T. ⁽¹⁾, KAIHARA T. ⁽²⁾, KUWATA S. ⁽¹⁾, KOGA M. ⁽¹⁾, WATANABE M. ⁽¹⁾, OKUYAMA K. ⁽¹⁾, KAMIJIMA R. ⁽¹⁾, IZUMO M. ⁽¹⁾, ISHIBASHI Y. ⁽¹⁾, TANABE Y. ⁽¹⁾, HIGUMA T. ⁽¹⁾, AKASHI Y. ⁽¹⁾
(1) St. Marianna University School of Medicine, Kanagawa JAPAN
(2) ,

Tokyo20A-OP019

Importance of combined assessment of skeletal muscle mass and density by CT in predicting clinical outcomes after TAVR

TOKUDA T. ⁽¹⁾, YAMAMOTO M. ⁽²⁾, OTSUKA T. ⁽³⁾, TADA N. ⁽⁴⁾, NAGANUMA T. ⁽⁵⁾, YAMANAKA F. ⁽⁶⁾, SHIRAI S. ⁽⁷⁾, MIZUTANI K. ⁽⁸⁾, TABATA M. ⁽⁹⁾, UENO H. ⁽¹⁰⁾, HIGASHIMORI A. ⁽¹¹⁾, ARAKI M. ⁽¹²⁾, WATANABE Y. ⁽¹³⁾, HAYASHIDA K. ⁽¹⁴⁾
(1) Nagoya heart center, Aichi JAPAN
(2) Toyohashi heart center, Aichi JAPAN
(3) Nippon Medical School Hospital, Tokyo JAPAN
(4) Sendai Kousei Hospital, Miyagi JAPAN
(5) New Tokyo Hospital, Chiba JAPAN
(6) Shonan Kamakura General Hospital, Kanagawa JAPAN
(7) Kokura Memorial Hospital, Fukuoka JAPAN
(8) Osaka City General Hospital, Osaka JAPAN
(9) Tokyo Bay Urayasu Ichikawa Medical Center, Chiba JAPAN
(10) toyama university hospital, Toyama JAPAN
(11) Kishiwada Tokushukai Hospital, Osaka JAPAN
(12) Saiseikai Yokohamashi Tobu Hospital, Kanagawa JAPAN
(13) Teikyo University, Tokyo JAPAN
(14) Keio University, Tokyo JAPAN

Tokyo20A-OP021

A combination of malnutrition and muscle weakness deteriorates clinical outcomes after TAVR

UCHIDA Y. ⁽¹⁾, TAMENISHI A. ⁽¹⁾, ICHIMIYA H. ⁽¹⁾, WATANABE J. ⁽¹⁾, KANASHIRO M. ⁽¹⁾, ICHIMIYA S. ⁽¹⁾
(1) Yokkaichi Municipal Hospital, Mie JAPAN

Tokyo20A-OP023

Clinical sequelae and determinants of subclinical leaflet thrombosis following TAVI with 320-multislice CT at medium term follow-up

RASHID H. ⁽¹⁾, MICHAIL M. ⁽¹⁾, KHAV N. ⁽¹⁾, IHDAYHID A. ⁽¹⁾, TAN S. ⁽¹⁾, CAMERON J. ⁽¹⁾, NASIS A. ⁽¹⁾, GOOLEY R. ⁽¹⁾
(1) Monash Medical Centre, VIC AUSTRALIA

Tokyo20A-OP024

Large bore vessel closure by MANTA - Avoiding post-closure vessel stenosis

BAUERNSCHMITT R. ⁽¹⁾, GUZMAN J. ⁽¹⁾, GRUNEBAUM J. P. ⁽¹⁾, SODIAN R. ⁽¹⁾
(1) MediClin Heart Center Lahr / Baden, Lahr GERMANY

Tokyo20A-POS001

Haemolytic anaemia induced by MitraClip

YUKIO O. ⁽¹⁾, YUKIO O. ⁽²⁾, OZAKI Y. ⁽¹⁾, OZAKI Y. ⁽²⁾, YOSHIKI Y. ⁽²⁾, HASHIMOTO Y. ⁽²⁾, TAKATSU H. ⁽²⁾, TORIYA T. ⁽²⁾, NAGASAKA R. ⁽²⁾, OHOTA M. ⁽²⁾, MURAMATSU T. ⁽²⁾
(1) ,
(2) Fujita Health University Hospital, Aichi JAPAN

Tokyo20A-POS003

Clinical outcomes and echocardiographic risk stratification in patients with moderate aortic stenosis and reduced left ventricular ejection fraction

ONISHI H. ⁽¹⁾, IZUMO M. ⁽²⁾, NAGANUMA T. ⁽¹⁾, MITOMO S. ⁽¹⁾, AKASHI Y. ⁽²⁾, NAKAMURA S. ⁽¹⁾
(1) New Tokyo Hospital, Chiba JAPAN
(2) St. Marianna University School of Medicine Yokohama City Seibu Hospital, Kanagawa JAPAN

Tokyo20A-POS004

Thrombocytopenia after transfemoral TAVI

UN K. C. ⁽¹⁾, WONG C. K. ⁽¹⁾, LAM C. C. ⁽¹⁾, CHAN T. L. ⁽¹⁾, TSE H. F. ⁽¹⁾
(1) Queen Mary Hospital, Pok Fu Lam HONG KONG

Tokyo20A-POS005

Impact of persistent right ventricular dysfunction on outcomes in patients with concomitant tricuspid regurgitation undergoing TAVI

DE JONGH M. ⁽¹⁾, TSURUTA H. ⁽¹⁾, HASE H. ⁽¹⁾, YOSHIJIMA N. ⁽¹⁾, SAITO T. ⁽¹⁾, MYOJIN S. ⁽¹⁾, KOBARI Y. ⁽¹⁾, RYUZAKI T. ⁽¹⁾, ITABASHI Y. ⁽¹⁾, HAYASHDA K. ⁽¹⁾, FUKUDA K. ⁽¹⁾
(1) Keio University, Tokyo JAPAN

Tokyo20A-POS006

Transcatheter vs. surgical aortic valve replacement for treatment of bicuspid aortic valve stenosis

FUJITA B. ⁽¹⁾, BOZKURT K. ⁽¹⁾, SAAD M. ⁽¹⁾, EMMEL E. ⁽¹⁾, EITEL I. ⁽¹⁾, ABOUD A. ⁽¹⁾, LANGER H. ⁽¹⁾, ENSMINGER S. ⁽¹⁾, KURZ T. ⁽¹⁾
(1) Lübeck Uniklinik, Lübeck GERMANY

Tokyo20A-POS007

Safety and feasibility of rotational atherectomy in severe aortic stenosis

BHATIA K. ⁽¹⁾, SRITHARAN H. ⁽¹⁾, ALLAHWALA U. ⁽¹⁾, WARD M. ⁽¹⁾, BHINDI R. ⁽¹⁾
(1) Royal North Shore Hospital, NSW AUSTRALIA

Tokyo20A-POS008

TAVI with Evolut R vs. Sapien 3 in small aortic annulus: the OCEAN-TAVI registry

HASE H. ⁽¹⁾, YOSHIJIMA N. ⁽¹⁾, SAITO T. ⁽¹⁾, KOBARI Y. ⁽¹⁾, MYOUJIN S. ⁽¹⁾, RYUZAKI T. ⁽¹⁾, TAKAHASHI T. ⁽¹⁾, ITABASHI Y. ⁽¹⁾, TSURUTA H. ⁽¹⁾, HAYASHIDA K. ⁽¹⁾, SHIMIZU H. ⁽¹⁾
(1) Keio University, Tokyo JAPAN

Tokyo20A-POS010

TAVR with the new balloon-expandable SAPIEN 3 Ultra vs. SAPIEN 3 valve system

MORIYAMA N. ⁽¹⁾, LAINE M. ⁽¹⁾
(1) Helsiki University Central Hospital, Helsinki FINLAND

Tokyo20A-POS012

Frailty assessment as predictors of outcomes for TAVI

KOH J. Q. S. ⁽¹⁾, MOHAMED RAHIM N. B. ⁽¹⁾, SNG E. L. ⁽¹⁾, YAP J. ⁽¹⁾, ZHONG L. ⁽¹⁾, LIM S. T. ⁽¹⁾, EWE S. H. ⁽¹⁾, CHAO V. ⁽¹⁾, HO K. W. ⁽¹⁾
(1) National Heart Centre Singapore, National Heart Centre Singapore SINGAPORE

Lond19A-OP001

30-day outcomes from a global early feasibility study to assess the safety and effectiveness of a novel transfemoral TAVR system for the treatment of patients with symptomatic severe aortic regurgitation

VAHL T. ⁽¹⁾, LEON M. ⁽¹⁾, BALDUS S. ⁽²⁾, THOURANI V. ⁽³⁾, TREEDE H. ⁽⁴⁾, MAKKAR R. ⁽⁵⁾, KODALI S. ⁽¹⁾, VAN MIEGHEM N. ⁽⁶⁾, RUDOLPH T. ⁽⁷⁾, WALTHER T. ⁽⁸⁾
(1) Columbia University, NY UNITED STATES
(2) Uniklinik Köln, Cologne GERMANY
(3) MedStar Washington Hospital Center, DC UNITED STATES
(4) UKB University of Bonn, Bonn GERMANY
(5) Cedars-Sinai Medical Center, CA UNITED STATES
(6) Erasmus Universiteit Rotterdam, Rotterdam NETHERLANDS
(7) HDZ NRW, Bad Oeynhausen GERMANY
(8) Universitätsklinikum Frankfurt, Frankfurt GERMANY

Lond19A-OP002

Propensity score matched analysis between TAVI and isolated surgical aortic valve implantation in young high-risk patients aged 75 years or less

MACH M. ⁽¹⁾, SLAKOV U. ⁽²⁾, WALLMüLLER C. ⁽³⁾, KEIL C. ⁽³⁾, STRATIL P. ⁽³⁾, STROUHAL A. ⁽³⁾, ADLBRECHT C. ⁽³⁾, DELLE-KARTH G. ⁽³⁾, GRABENWöGER M. ⁽²⁾, SCHOBER A. ⁽³⁾
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

Lond19A-OP004

A novel heart failure score predicts adverse outcome in patients undergoing TAVI

MACH M. ⁽¹⁾, WINKLER B. ⁽²⁾, SCHOBER A. ⁽³⁾, STROUHAL A. ⁽³⁾, DELLE-KARTH G. ⁽³⁾, GRABENWöGER M. ⁽²⁾, ADLBRECHT C. ⁽³⁾
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

Lond19A-OP005

The FIFA-trial: FItness-tracker assisted Frailty-Assessment before TAVI

MACH M. ⁽¹⁾, WATZAL V. ⁽²⁾, WINKLER B. ⁽²⁾, STROUHAL A. ⁽³⁾, ADLBRECHT C. ⁽³⁾, DELLE-KARTH G. ⁽³⁾, GRABENWöGER M. ⁽²⁾
(1) Medical University of Vienna, Department of Cardiac Surgery, Vienna AUSTRIA
(2) Hospital Hietzing, Department of Cardiothoracic and Vascular Surgery, Vienna AUSTRIA
(3) Hospital Hietzing, Department of Cardiology, Vienna AUSTRIA

Lond19A-OP006

Predictors of permanent pacemaker implantation after TAVI in patients with very large annuli with a self-expanding valve

JIMENEZ V. A. ⁽¹⁾, JIMENEZ DIAZ V. A. ⁽¹⁾, LOPEZ OTERO D. ⁽²⁾, CRUZ GONZALEZ I. ⁽³⁾, AMAT-SANTOS I. ⁽⁴⁾, RIVERO F. ⁽⁵⁾, GUTIERREZ IBAñEZ E. ⁽⁶⁾, MUñOZ GARCIA A. ⁽⁷⁾, VAQUERIZO B. ⁽⁸⁾, MORENO SAMOS J. C. ⁽³⁾, RODRIGUEZ-GABELLA T. ⁽⁴⁾, GONZALEZ SALDIVAR H. ⁽⁶⁾
(1) Hospital Álvaro Cunqueiro, Vigo SPAIN
(2) Hospital Universitario de Santiago de Compostela, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

Lond19A-OP007

Very early discharge after transfemoral TAVI in selected patients; is it safe?

CALABUIG A. ⁽¹⁾, VICENS S. ⁽¹⁾, MARTI G. ⁽¹⁾, SERRA B. ⁽¹⁾, OTAEGUI I. ⁽¹⁾, DOMINGO E. ⁽¹⁾, BELLERA N. ⁽¹⁾, DIAZ M. ⁽¹⁾, SUASNAVAR P. ⁽¹⁾, GONZALEZ S. ⁽¹⁾, GARCIA B. ⁽¹⁾
(1) Vall d'Hebron University Hospital, Barcelona SPAIN

Lond19A-OP008

The concept of futility in treating functional mitral regurgitation in real world

GAVAZZONI M. ⁽¹⁾, ADAMO M. ⁽²⁾, ESTéVEZ LOUREIRO R. ⁽³⁾, POZZOLI A. ⁽¹⁾, CURELLO S. ⁽²⁾, BENITO T. ⁽³⁾, PORTOLèS A. ⁽⁴⁾, MIZUKI M. ⁽¹⁾, SCIANNA S. ⁽¹⁾, ZUBER M. ⁽¹⁾, TARAMASSO M. ⁽¹⁾, MAISANO F. ⁽¹⁾
(1) Universitätsspital Zürich, Zürich SWITZERLAND
(2) Spedali Civili, Piazzale Spedali Civili, Brescia, Province of Brescia ITALY
(3) university hospital, León SPAIN
(4) Hospital Puerta De Hierro, Majadahonda SPAIN

Lond19A-OP009

Systematic cerebral protection during TAVI: a single-centre experience

PIVA T. ⁽¹⁾, NICOLINI E. ⁽¹⁾, MUCAJ A. ⁽¹⁾, ALESSANDRO M. ⁽¹⁾, MIRCO B. ⁽¹⁾, ANDREA A. ⁽¹⁾, MASSIMILIANO S. ⁽¹⁾, ALESSANDRO A. ⁽¹⁾, GABRIELE G. ⁽¹⁾
(1) Ospedali Riuniti, Province of Ancona ITALY

Lond19A-OP010

Clinical data, performance and safety of TAVI in very large annuli with a self-expandable valve

JIMENEZ V. A. ⁽¹⁾, JIMENEZ V. ⁽¹⁾, LOPEZ-OTERO D. ⁽²⁾, CRUZ-GONZALEZ I. ⁽³⁾, AMAT-SANTOS I. ⁽⁴⁾, RIVERO F. ⁽⁵⁾, GUTIERREZ IBAñEZ E. ⁽⁶⁾, MUñOZ GARCIA A. ⁽⁷⁾, VAQUERIZO B. ⁽⁸⁾, TRILLO NOUCHE R. ⁽²⁾, MORENO SAMOS J. C. ⁽³⁾, RODRIGUEZ-GABELLA T. ⁽⁴⁾
(1) Álvaro Cunqueiro Hospital, Vigo SPAIN
(2) Hospital, Santiago de Compostela SPAIN
(3) Hospital Clínico Universitario de Salamanca, Salamanca SPAIN
(4) Hospital Clínico Universitario de Valladolid, Valladolid SPAIN
(5) Hospital de La Princesa, Madrid SPAIN
(6) Gregorio Marañón Hospital, Madrid SPAIN
(7) Hospital Universitario Virgen de la Victoria, Málaga SPAIN
(8) Hospital del Mar, Barcelona SPAIN

Lond19A-OP011

First mid-/long-term follow-up results in patients undergoing TAVR with the self-expandable Portico valve for severe aortic stenosis: a real-world prospective study

MAS-PEIRO S. ⁽¹⁾, SEPPELT P. C. ⁽¹⁾, DE ROSA R. ⁽¹⁾, MURRAY M. I. ⁽¹⁾, WALTHER T. ⁽¹⁾, ZEIHER A. M. ⁽¹⁾, FICHTLSCHERER S. ⁽¹⁾, VASA-NICOTERA M. ⁽¹⁾
(1) University Hospital Frankfurt, Frankfurt am Main GERMANY

Lond19A-OP012

Long-term experience with mechanical aortic valve prostheses after one-third of a century

AREF T. ⁽¹⁾, WIEDEMANN D. ⁽¹⁾, ROSENHEK R. ⁽¹⁾, HIESMAYR M. ⁽¹⁾, KOCHER A. ⁽¹⁾, ANDREAS M. ⁽¹⁾
(1) Medical University of Vienna, Vienna AUSTRIA

Lond19A-OP013

Assessment of right atrial deformation indices in patients with different scales of significant secondary tricuspid regurgitation

OKUTUCU S. ⁽¹⁾, SIMSEK V. ⁽¹⁾, AKSOY H. ⁽¹⁾, BURSA N. ⁽²⁾, YETIS SAYIN B. ⁽¹⁾, OTO A. ⁽¹⁾
(1) Memorial Ankara Hastanesi, Ankara TURKEY
(2) Hacettepe Üniversitesi Beytepe Kampüsü, Ankara TURKEY

Lond19A-OP014

A prospective multicentre study of the SAPIEN 3 Ultra system in intermediate-risk patients with severe aortic stenosis

PRENDERGAST B. ⁽¹⁾, HORLICK E. ⁽²⁾, RODES-CABAU J. ⁽³⁾, MACCARTHY P. ⁽⁴⁾, VELIANOU J. ⁽⁵⁾, WOOD D. ⁽⁶⁾, HOVORKA T. ⁽⁷⁾, WEBB J. ⁽⁸⁾
(1) Guy's and St Thomas' NHS Foundation Trust, London UNITED KINGDOM
(2) Toronto General Hospital, ON CANADA
(3) Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), QC CANADA
(4) King's College Hospital NHS Foundation Trust, London UNITED KINGDOM
(5) Hamilton Health Sciences, McMaster University, Hamilton, ON, Hamilton CANADA
(6) St. Paul's Hospital, University of British Columbia, Vancouver, BC, Vancouver CANADA
(7) Edwards Lifesciences, Prague, Prague CZECH REPUBLIC
(8) St. Paul's Hospital, University of British Columbia, Vancouver CANADA

Lond19A-OP015

Five-year clinical outcomes after percutaneous edge-to-edge mitral valve repair: insights from the multicentre GRASP-IT registry

ADAMO M. ⁽¹⁾, GRASSO C. ⁽²⁾, POPOLO RUBBIO A. ⁽²⁾, CAPODANNO D. ⁽²⁾, CRISTINA G. ⁽³⁾, FIORELLI F. ⁽³⁾, PETRONIO A. S. ⁽³⁾, BEDOGNI F. ⁽⁴⁾, CURELLO S. ⁽¹⁾, TAMBURINO C. ⁽²⁾
(1) Spedali Civili of Brescia , Brescia ITALY
(2) CAST Policlinico Vittorio Emanuele, Catania ITALY
(3) AUOP Piasana, Pisa ITALY
(4) IRCCS Policlinico San Donato, Milano ITALY

Lond19A-OP016

Neurological events from the Evolut low-risk study

TCHETCHE D. ⁽¹⁾, POPMA J. ⁽²⁾, YAKUBOV S. ⁽³⁾, DEEB G. M. ⁽⁴⁾, GLEASON T. ⁽⁵⁾, KLEIMAN N. ⁽⁶⁾, WALTON A. ⁽⁷⁾, REARDON M. ⁽⁶⁾
(1) Clinic Pasteur, Toulouse FRANCE
(2) Beth Israel Deaconess Medical Center (BIDMC), MA UNITED STATES
(3) Riverside Methodist Hospital, OH UNITED STATES
(4) University of Michigan, MI UNITED STATES
(5) University of Pittsburgh, PA UNITED STATES
(6) Methodist Debakey Heart and Vascular Center, TX UNITED STATES
(7) The Alfred Hospital, VIC AUSTRALIA

Lond19A-OP017

Valve-in-valve implantation using the ACURATE neo in degenerated aortic bioprostheses: an international multicentre analysis

TOGGWEILER S. ⁽¹⁾, HOLZAMER A. ⁽²⁾, KIM W. K. ⁽³⁾, SATHANANTHAN J. ⁽⁴⁾, KELLER L. ⁽⁵⁾, BRINKERT M. ⁽¹⁾, HILKER M. ⁽²⁾, NIETLISPACH F. ⁽⁵⁾, WEBB J. ⁽⁴⁾
(1) Luzerner Kantonsspital, Lucerne SWITZERLAND
(2) Universitätsklinikum Regensburg, Regensburg GERMANY
(3) Bad Nauheimer Klinik, Bad Nauheim GERMANY
(4) St Pauls Hospital, BC CANADA
(5) Universitätsspital Zürich, Zürich SWITZERLAND

Lond19A-OP018

Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new European definition - A multicentre French study

SOKOLOFF A. ⁽¹⁾, DURAND E. ⁽²⁾, URENA ALCAZAR M. ⁽³⁾, HIMBERT D. ⁽³⁾, IUNG B. ⁽³⁾, BLANCHARD D. ⁽⁴⁾, GILARD M. ⁽⁵⁾, CRIBER A. ⁽²⁾, LEFEVRE T. ⁽⁶⁾, ELTCHANINOFF H. ⁽²⁾
(1) INSTITUT MUTUALISTE MONTSOURIS, PARIS FRANCE
(2) HOPITAL CHARLES NICOLLE CHU ROUEN, ROUEN FRANCE
(3) Bichat-Claude Bernard Hospital, Paris FRANCE
(4) CLINIQUE SAINT-GATIEN - TOURS, TOURS FRANCE
(5) CHRU BREST SITE HOPITAL MORVAN, BREST FRANCE
(6) Cardiovascular Institute Paris Sud (ICPS), Massy FRANCE

Lond19A-OP019

A set of pre-specified risk criteria facilitates appropriately timed discharge and sustained outcomes to one year after hospital discharge for patients having transfemoral TAVI based on the FAST TAVI trial

SPENCE M. ⁽¹⁾, BAAN J. ⁽²⁾, MARTINELLI G. L. ⁽³⁾, MUIR D. F. ⁽⁴⁾, SAIA F. ⁽⁵⁾, BORTONE A. ⁽⁶⁾, DENSEM C. G. ⁽⁷⁾, VAN DER KLEY F. ⁽⁸⁾, VAN MOURIK M. S. ⁽²⁾, BRAMLAGE P. ⁽⁹⁾, BARBANTI M. ⁽¹⁰⁾
(1) Royal Victoria Hospital, Belfast UNITED KINGDOM
(2) UMCA - Locatie AMC, Amsterdam NETHERLANDS
(3) Clinica San Gaudenzio, Province of Novara ITALY
(4) The James Cook University Hospital, Middlesbrough UNITED KINGDOM
(5) S Orsola Malpighi Pad 5, Metropolitan City of Bologna ITALY
(6) University of Bari Aldo Moro, Metropolitan City of Bari ITALY
(7) Papworth Trust, Cambridge UNITED KINGDOM
(8) Leiden University Medical Center (LUMC), Leiden NETHERLANDS
(9) Institute for Pharmacology and Preventive Medicine, Cloppenburg GERMANY
(10) Policlinico ?Vittorio Emanuele?, Province of Catania ITALY

Lond19A-OP021

Transcatheter treatment of bicuspid aortic valves with the Evolut platform: interim analysis from the BIVOLUT-X registry

TCHETCHE D. ⁽¹⁾, DE BIASE C. ⁽¹⁾, ZIVIELLO F. ⁽²⁾, HOVASSE T. ⁽³⁾, SONDERGAARD L. ⁽⁴⁾, TEIGER E. ⁽⁵⁾, TELES R. ⁽⁶⁾, DUMONTEIL N. ⁽¹⁾, VAN MIEGHEM N. ⁽²⁾
(1) CLINIQUE PASTEUR, TOULOUSE FRANCE
(2) Erasmus MC, Rotterdam NETHERLANDS
(3) HOPITAL PRIVE JACQUES CARTIER, MASSY FRANCE
(4) Rigshospitalet, Copenhagen Municipality DENMARK
(5) HU HENRI MONDOR SITE HENRI MONDOR APHP, CRETEIL FRANCE
(6) Santa Cruz Hospital, Lisbon PORTUGAL

Lond19A-OP022

Adoption of newer MDCT measurements can lower pacemaker rates after TAVR in a community hospital setting

CHRYSANT G. ⁽¹⁾, SPARLING J. ⁽¹⁾, BEAGLES J. ⁽¹⁾, CLARK C. ⁽¹⁾, ELKINS C. ⁽¹⁾
(1) INTEGRIS Baptist Medical Center, OK UNITED STATES

Lond19A-OP023

Clinical and echocardiographic impact of under and over expansion of SAPIEN 3 transcatheter heart valves to tailor to aortic annular sizes

ADUSUMALLI S. ⁽¹⁾, LAU K. ⁽¹⁾, ROPER D. ⁽¹⁾, SAVAGE M. ⁽¹⁾, RAFFEL C. ⁽¹⁾, SCALIA G. M. ⁽¹⁾, POON K. ⁽¹⁾
(1) The Prince Charles Hospital, QLD AUSTRALIA

Filter by

Keywords

Congress